ArticleFrontiers in oncology2022

OCT4 and SOX2 Specific Cytotoxic T Cells Exhibit Not Only Good Efficiency but Also Synergize PD-1 Inhibitor (Nivolumab) in Treating Breast Cancer Stem-Like Cells and Drug-Resistant Breast Cancer Mice.

Wei Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.